1H-Pyrazolo[3,4-d]pyrimidin-4-amine (BioDeep_00000173075)

   

human metabolite blood metabolite Antitumor activity Volatile Flavor Compounds


代谢物信息卡片


1H-Pyrazolo[3,4-d]pyrimidin-4-amine

化学式: C5H5N5 (135.054493)
中文名称: 4-氨基吡唑并[3,4-d]嘧啶, 1H-吡唑并[3,4-d]嘧啶-4-胺
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1=NNC2=NC=NC(=C21)N
InChI: InChI=1S/C5H5N5/c6-4-3-1-9-10-5(3)8-2-7-4/h1-2H,(H3,6,7,8,9,10)

描述信息

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
D009676 - Noxae > D000963 - Antimetabolites
Pyrazoloadenine is a potent RET (REarranged during Transfection) lung cancer oncoprotein inhibitor. Pyrazoloadenine shows anticancer activity[1][2].

同义名列表

7 个代谢物同义名

1H-Pyrazolo[3,4-d]pyrimidin-4-amine; 4-Aminopyrazolo[3,4-d]pyrimidine; 4-Aminopyrazolo(3,4-D)pyrimidine; Aminopurinol; 4APP-4; Pyrazoloadenine; 1H-Pyrazolo[3,4-d]pyrimidin-4-amine



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Jennifer K Leohr, Debra Luffer-Atlas, M Jane Luo, David J DeBrota, Colin Green, Thomas E Mabry, Jeffrey G Suico. Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1. Journal of clinical pharmacology. 2018 04; 58(4):412-424. doi: 10.1002/jcph.1032. [PMID: 29178617]
  • Thomas B Estridge, Asim B Dey, Charles Reidy, Xiaohong Yu, Yuke Zhang, Maryalice Hartley, Paul L Milligan, Najia Jin, Mark C Kowala, Jennifer K Leohr, Adrian J Fretland, Thomas E Mabry, Debra Luffer-Atlas, M Jane Luo. Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats. The Journal of pharmacology and experimental therapeutics. 2017 07; 362(1):108-118. doi: 10.1124/jpet.117.240242. [PMID: 28465372]
  • Jung-Feng Hsieh, Shih-Hsiung Wu, Yu-Liang Yang, Kee-Fong Choong, Shui-Tein Chen. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors. Bioorganic & medicinal chemistry. 2007 May; 15(10):3450-6. doi: 10.1016/j.bmc.2007.03.010. [PMID: 17379526]
  • M Brigotti, S Rizzi, D Carnicelli, L Montanaro, S Sperti. A survey of adenine and 4-aminopyrazolo[3,4-d]pyrimidine (4-APP) as inhibitors of ribosome-inactivating proteins (RIPs). Life sciences. 2000 Dec; 68(3):331-6. doi: 10.1016/s0024-3205(00)00941-3. [PMID: 11191648]
  • K G Davidson, S M Acton, H A Barr, T E Nicholas. Effect of lowering serum cholesterol on the composition of surfactant in adult rat lung. The American journal of physiology. 1997 Jan; 272(1 Pt 1):L106-14. doi: 10.1152/ajplung.1997.272.1.l106. [PMID: 9038909]
  • M Bertolotti, D K Spady. Effect of hypocholesterolemic doses of 17 alpha-ethinyl estradiol on cholesterol balance in liver and extrahepatic tissues. Journal of lipid research. 1996 Aug; 37(8):1812-22. doi: 10.1016/s0022-2275(20)39124-0. [PMID: 8864965]
  • K R Feingold, J L Funk, A H Moser, J K Shigenaga, J H Rapp, C Grunfeld. Role for circulating lipoproteins in protection from endotoxin toxicity. Infection and immunity. 1995 May; 63(5):2041-6. doi: 10.1128/iai.63.5.2041-2046.1995. [PMID: 7729918]
  • J F Goodrum, T W Bouldin, S H Zhang, N Maeda, B Popko. Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. Journal of neurochemistry. 1995 Jan; 64(1):408-16. doi: 10.1046/j.1471-4159.1995.64010408.x. [PMID: 7798939]
  • R F Aten, T R Kolodecik, H R Behrman. Ovarian vitamin E accumulation: evidence for a role of lipoproteins. Endocrinology. 1994 Aug; 135(2):533-9. doi: 10.1210/endo.135.2.8033800. [PMID: 8033800]
  • S Wu-Pong, P M Elias, K R Feingold. Influence of altered serum cholesterol levels and fasting on cutaneous cholesterol synthesis. The Journal of investigative dermatology. 1994 May; 102(5):799-802. doi: 10.1111/1523-1747.ep12378556. [PMID: 8176266]
  • T Minami, H Nakagawa, M Ichii, E Kadota, Y Okazaki. Nephrotoxicity induced by a single dose of adenine: effects of 4-aminopyrazolo[3,4-d]pyrimidine and allopurinol. Biological & pharmaceutical bulletin. 1994 Feb; 17(2):201-6. doi: 10.1248/bpb.17.201. [PMID: 8205116]
  • T Minami, H Nakagawa, S Yoshimoto, I Asano, Y Okazaki. Role of metallothionein in 4-aminopyrazolo[3,4-d]pyrimidine-administered mouse pancreas. Biological & pharmaceutical bulletin. 1993 Nov; 16(11):1108-10. doi: 10.1248/bpb.16.1108. [PMID: 8312865]
  • T Minami, K Natsui, H Nakagawa, Y Okazaki. The effect of 4-aminopyrazolo(3,4-d) pyrimidine on mouse plasma alpha-amylase activity. International journal of pancreatology : official journal of the International Association of Pancreatology. 1993 Jun; 13(3):169-74. doi: 10.1007/bf02924437. [PMID: 8370978]
  • J F Goodrum. Cholesterol synthesis in regenerating peripheral nerve is not influenced by serum cholesterol levels. Journal of neurochemistry. 1993 Apr; 60(4):1564-6. doi: 10.1111/j.1471-4159.1993.tb03322.x. [PMID: 8455042]
  • G Ning, T Fujimoto, H Koike, K Ogawa. Cholesterol ester in corpus luteum of rat observed by analytical color fluorescence electron microscopy. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1993 Apr; 41(4):617-25. doi: 10.1177/41.4.8450201. [PMID: 8450201]
  • B Rodrigues, J E Braun, M Spooner, D L Severson. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids. Canadian journal of physiology and pharmacology. 1992 Sep; 70(9):1271-9. doi: 10.1139/y92-176. [PMID: 1493594]
  • L K Malendowicz. Comparative studies on the effect of 4-APP(4-aminopyrazolopyrimidine) on hamster and rat adrenal cortex. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie. 1992 Jun; 44(3):134-7. doi: 10.1016/s0940-2993(11)80146-6. [PMID: 1324042]
  • A Kasprzak, P Rebuffat, J B Warchol, G Mazzocchi, G G Nussdorfer, L K Malendowicz. Effects of the hypocholesterolemic drug, 4-aminopyrazolo (3,4-d) pyrimidine (4-APP), on the hamster adrenal cortex. An ultrastructural and functional study. Virchows Archiv. B, Cell pathology including molecular pathology. 1991; 60(4):239-43. doi: 10.1007/bf02899552. [PMID: 1681612]
  • P G Andreis, L Cavallini, G Mazzocchi, V Meneghelli, G G Nussdorfer. Lipid droplets in the secretory response of Leydig cells of normal and hCG-treated rats. Journal of submicroscopic cytology and pathology. 1990 Jul; 22(3):361-6. doi: ". [PMID: 2167768]
  • J G Lehoux, A Lefebvre, S Bélisle, D Bellabarba. Effect of ACTH suppression on adrenal 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in 4-aminopyrazolopyrimidine-treated rats. Molecular and cellular endocrinology. 1990 Feb; 69(1):41-9. doi: 10.1016/0303-7207(90)90087-o. [PMID: 2157616]
  • S Azhar, D Stewart, E Reaven. Utilization of cholesterol-rich lipoproteins by perfused rat adrenals. Journal of lipid research. 1989 Nov; 30(11):1799-810. doi: ". [PMID: 2614279]
  • F Talavera, K M Menon. Regulation of rat luteal cell high density lipoprotein receptors: up-regulation in response to changes in intracellular cholesterol concentration. Endocrinology. 1989 Oct; 125(4):2015-21. doi: 10.1210/endo-125-4-2015. [PMID: 2791975]
  • E Reaven, M Spicher, S Azhar. Microvillar channels: a unique plasma membrane compartment for concentrating lipoproteins on the surface of rat adrenal cortical cells. Journal of lipid research. 1989 Oct; 30(10):1551-60. doi: NULL. [PMID: 2614258]
  • T Torlińska, L K Malendowicz, J Paluszak, J Koźlik, M Nowak, K W Nowak, J Godlewski. The effect of 4-aminopyrazolo (3,4-d) pyrimidine (4-APP) on some parameters of carbohydrate metabolism in the rat. Acta physiologica Polonica. 1989 Sep; 40(5-6):530-4. doi: NULL. [PMID: 2488750]
  • J G Lehoux, A Lefebvre, S Bélisle, D Bellabarba. Hormonal regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in the rat adrenal gland. Journal of steroid biochemistry. 1989; 34(1-6):379-84. doi: 10.1016/0022-4731(89)90112-x. [PMID: 2560519]
  • A S Belloni, P Rebuffat, G Neri, G Mazzocchi, V Meneghelli, G G Nussdorfer. Effects of 4-aminopyrazolo (3,4-d) pyrimidine on rat hepatocytes: an ultrastructural morphometric study. Histology and histopathology. 1989 Jan; 4(1):31-7. doi: ". [PMID: 2485187]
  • G Mazzocchi, P Rebuffat, A S Belloni, G Gottardo, V Meneghelli, G G Nussdorfer. Effects of mevinolin, an inhibitor of cholesterol synthesis, on the morphological and functional responses of rat adrenal zona fasciculata to a prolonged treatment with 4-aminopyrazolo-pyrimidine. The Anatomical record. 1988 Jul; 221(3):700-6. doi: 10.1002/ar.1092210304. [PMID: 3189865]
  • J W Aitken, R Booth, D A Stansfield. Luteal progesterone synthesis and high-density lipoprotein. Evidence implicating a pronase-sensitive HDL-binding site in the mechanism by which HDL supports luteal progesterone synthesis. European journal of biochemistry. 1988 Jan; 171(1-2):279-84. doi: 10.1111/j.1432-1033.1988.tb13787.x. [PMID: 3338466]
  • K R Feingold, A H Moser. Effect of hypocholesterolemia on cholesterol synthesis in small intestine of diabetic rats. Diabetes. 1987 Nov; 36(11):1223-9. doi: 10.2337/diab.36.11.1223. [PMID: 3666315]
  • F Rinninger, R C Pittman. Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters. Journal of lipid research. 1987 Nov; 28(11):1313-25. doi: 10.1016/s0022-2275(20)38596-5. [PMID: 3430062]
  • G Mazzocchi, C Robba, V Meneghelli, G G Nussdorfer. Effects of ACTH and aminoglutethimide administration on the morphological and functional responses of rat adrenal zona fasciculata to a prolonged treatment with 4-aminopyrazolo-pyrimidine. Journal of anatomy. 1987 Oct; 154(?):55-61. doi: . [PMID: 2833484]
  • L K Malendowicz, M Nowak, J Paluszak, T Torlińska. Adrenocortical function in 4-APP treated rats: a coupled stereological and biochemical study. Journal of steroid biochemistry. 1987 Apr; 26(4):487-92. doi: 10.1016/0022-4731(87)90061-6. [PMID: 3035285]
  • J B Miller, M P McLean. Evidence for the preferential utilization of esterified cholesterol in progesterone production by rabbit corpora lutea. Biology of reproduction. 1987 Apr; 36(3):729-39. doi: 10.1095/biolreprod36.3.729. [PMID: 3593844]
  • M Nowak, M Majchrzak, L K Malendowicz. Stereologic studies on the adrenal cortex of 4-APP (4-amino-pyrazolopyrimidine)-induced lipoprotein-deficient rats. Experimental pathology. 1987; 31(3):169-73. doi: 10.1016/s0232-1513(87)80103-2. [PMID: 3609240]
  • G Mazzocchi, C Robba, V Meneghelli, G G Nussdorfer. Long term effects of the hypocholesterolaemic drug 4-aminopyrazolo-pyrimidine on the zona fasciculata of the rat adrenal cortex. Journal of anatomy. 1986 Dec; 149(?):1-9. doi: NULL. [PMID: 3693098]
  • H Almeida, M M Magalhães, T A Serra, C Hipólito-Reis, M C Magalhães. Ultrastructural and biochemical alterations produced in rat adrenal cortex by 4-aminopyrazolopyrimidine. Journal of ultrastructure and molecular structure research. 1986 Oct; 97(1-3):1-9. doi: 10.1016/s0889-1605(86)80002-7. [PMID: 3453362]
  • C Petrou, R Booth, D A Stansfield. Stimulation of progesterone synthesis, in corpus luteum cells isolated from 4-amino-3,4-d-pyrazolopyrimidine-treated rats, by cholesterol presented in non-lipoprotein form. FEBS letters. 1986 Aug; 204(2):381-5. doi: 10.1016/0014-5793(86)80848-1. [PMID: 3732521]
  • C M Schiller, C M Adcock, C R Shoaf, R Walden. Effects of adenine and its isomer 4-aminopyrazolo-[3,4-d]-pyrimidine on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced mortality in rats. Toxicology and applied pharmacology. 1986 Jun; 84(2):369-78. doi: 10.1016/0041-008x(86)90145-6. [PMID: 3715883]
  • F M van 't Hooft, A van Tol. Effect of 4-aminopyrazolo[3,4-d]pyrimidine on the catabolism of high-density lipoprotein apolipoprotein A-I in the rat. Biochimica et biophysica acta. 1986 Apr; 876(2):333-9. doi: 10.1016/0005-2760(86)90292-4. [PMID: 3082368]
  • M S Blank, M Ching, K J Catt, M L Dufau. Inhibition of gonadotropin-releasing hormone release as the basis of pituitary-gonadal dysfunction during treatment with 4-aminopyrazolo-(3,4-d)-pyrimidine. Endocrinology. 1985 May; 116(5):1778-83. doi: 10.1210/endo-116-5-1778. [PMID: 3886368]
  • F M van 't Hooft, A van Tol. In vivo catabolism of human low density lipoprotein in the rat is mediated by a nonsaturable, low-affinity mechanism. FEBS letters. 1985 Apr; 183(1):138-42. doi: 10.1016/0014-5793(85)80971-6. [PMID: 3838517]
  • M Murakoshi, Y Osamura, K Watanabe. Ultrastructural studies in 4-aminopyrazolopyrimidine (4-APP)-induced fatty liver. The Tokai journal of experimental and clinical medicine. 1985 Apr; 10(1):5-12. doi: ". [PMID: 4095713]
  • K Rajkumar, R L Couture, B D Murphy. Binding of high-density lipoproteins to luteal membranes: the role of prolactin, luteinizing hormone, and circulating lipoproteins. Biology of reproduction. 1985 Apr; 32(3):546-55. doi: 10.1095/biolreprod32.3.546. [PMID: 2986739]
  • M Murakoshi, Y Osamura, K Watanabe. Ultrastructural changes in rat adrenocortical cells produced by a 4-aminopyrazolopyrimidine (4-APP) dosage. Cell structure and function. 1984 Mar; 9(1):13-23. doi: 10.1247/csf.9.13. [PMID: 6722907]
  • K Mikami, T Nishikawa, Y Saito, Y Tamura, N Matsuoka, A Kumagai, S Yoshida. Regulation of cholesterol metabolism in rat adrenal glands: effect of adrenocorticotropin, cholesterol, and corticosteroids on acyl-coenzyme A synthetase and cholesterol ester hydrolases. Endocrinology. 1984 Jan; 114(1):136-40. doi: 10.1210/endo-114-1-136. [PMID: 6317339]
  • D Szabó, K S Szalay, I E Tóth. Correlation of lipid droplet content and steroidogenic capacity in zona glomerulosa and fasciculata cells from lipoprotein-deficient rats. Molecular and cellular endocrinology. 1984 Jan; 34(1):59-66. doi: 10.1016/0303-7207(84)90159-x. [PMID: 6321276]
  • L G Paavola, J F Strauss. Uptake of lipoproteins by in situ perfused rat ovaries: identification of binding sites for high density lipoproteins. The Journal of cell biology. 1983 Sep; 97(3):593-606. doi: 10.1083/jcb.97.3.593. [PMID: 6309865]
  • M S Blank, E Loumaye, D S Sgoutas, K J Catt, M L Dufau. Inhibition of pituitary gonadotropin secretion by 4-aminopyrazolo(3,4-d) pyrimidine. Endocrinology. 1983 Jun; 112(6):1973-9. doi: 10.1210/endo-112-6-1973. [PMID: 6406206]
  • E Vijayan, K Raju. Substance P and neurotensin: opposite effects on plasma cholesterol levels in ovariectomized conscious rats. Experientia. 1982 Jul; 38(7):863-4. doi: 10.1007/bf01972320. [PMID: 6179790]
  • B C Bruot, W G Wiest, D C Collins. Effect of low density and high density lipoproteins on progesterone secretion by dispersed corpora luteal cells from rats treated with aminopyrazolo-(3,4-d)pyrimidine. Endocrinology. 1982 May; 110(5):1572-8. doi: 10.1210/endo-110-5-1572. [PMID: 7075531]
  • S Azhar, K M Menon. Receptor mediated gonadotropin action in gonadal tissues: relationship between blood cholesterol levels and gonadotropin stimulated steroidogenesis in isolated rat Leydig and luteal cells. Journal of steroid biochemistry. 1982 Feb; 16(2):175-84. doi: 10.1016/0022-4731(82)90165-0. [PMID: 7078156]
  • M Ascoli. Effects of hypocholesterolemia and chronic hormonal stimulation on sterol and steroid metabolism in a Leydig cell tumor. Journal of lipid research. 1981 Nov; 22(8):1247-53. doi: 10.1016/s0022-2275(20)37317-x. [PMID: 7320635]
  • K R Feingold, M H Wiley, G MacRae, M D Siperstein. The effect of decreased plasma cholesterol concentration on circulatinga mevalonate metabolism in rats. Journal of lipid research. 1981 Aug; 22(6):990-7. doi: 10.1016/s0022-2275(20)37336-3. [PMID: 7276756]
  • K Raju, E Vijayan. Neurotensin and substance P: differential effects on plasma cholesterol levels in conscious ovariectomized rats. Regulatory peptides. 1981 Aug; 2(4):265-74. doi: 10.1016/0167-0115(81)90030-6. [PMID: 6169120]
  • B R Krause, C H Sloop, P S Roheim. Lipid absorption in unanesthetized, unrestrained rats. Effects of 4-aminopyrazolopyrimidine and ethinyl estradiol. Biochimica et biophysica acta. 1981 Jul; 665(1):165-9. doi: 10.1016/0005-2760(81)90244-7. [PMID: 7284414]
  • L A Schuler, M E Toaff, J F Strauss. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase. Endocrinology. 1981 Apr; 108(4):1476-86. doi: 10.1210/endo-108-4-1476. [PMID: 7472277]
  • Y Suzuki, R Tabata. Selective reduction of phosphatidylglycerol and phosphatidylcholine in pulmonary surfactant by 4-aminopyrazolo(3,4d)pyrimidine in the rat. Journal of lipid research. 1980 Nov; 21(8):1090-6. doi: 10.1016/s0022-2275(20)34770-2. [PMID: 6893998]
  • D Szabó, J Somogyi, Z Acs, K Mihály. Zonal differences in the distribution and morphology of lipid droplets using 4-amino-pyrazolo-(3,4 d) pyrimidine to lower cholesterol level in the rat adrenal. Acta biologica Academiae Scientiarum Hungaricae. 1980; 31(1-3):283-90. doi: ". [PMID: 7223240]
  • M S Brown, P T Kovanen, J L Goldstein. Evolution of the LDL receptor concept-from cultured cells to intact animals. Annals of the New York Academy of Sciences. 1980; 348(?):48-68. doi: 10.1111/j.1749-6632.1980.tb21290.x. [PMID: 6994567]